# A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

> **NCT06476665** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Acute Lymphocytic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06476665
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-07
- **Primary completion:** 2029-06-22
- **Final completion:** 2029-06-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06476665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06476665, "A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06476665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*